THI and Rice Baker Institute Host Fifth Texas Stem Cell Research and Public Policy
HOUSTON, TX – June 2021 – Drs. Kirstin Matthews (Baker Institute) and Emerson Perin (THI) spearhead a joint research and lecture series. The goal of the series is to engage with policymakers and the general public to discuss the risk and concerns related to the marketing of unproven stem cell treatments as well as other Texas-related policy issues. The 2021 event is the fifth in the series and focused on the importance of clinical trials, new data on the uses of cell-based therapies to treat heart disease, and the risk of providing unproven stem cell treatments.
2016 STEM CELL TOURISM NEAR AND FAR: ACHIEVING A COMPROMISE FOR THE PATIENT
2017 CHARLIE’S LAW: INCREASED ACCESS TO STEM CELL INTERVENTIONS IN TEXAS
2019 TEXAS’ STEM CELL FUTURE: ACCESSING OUTCOME DATA FROM EXPERIMENTAL INTERVENTIONS
2020 STEM CELL THERAPIES 2020: ARE WE THERE YET?
2021 WEBINAR — REGENERATIVE MEDICINE: PROVEN TREATMENTS, UNPROVEN TREATMENTS, AND THE POLICIES THAT PROMOTE BOTH